These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32836625)

  • 1. Quantum dots as a promising agent to combat COVID-19.
    Manivannan S; Ponnuchamy K
    Appl Organomet Chem; 2020 Oct; 34(10):e5887. PubMed ID: 32836625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology: an emerging approach to combat COVID-19.
    Chintagunta AD; M SK; Nalluru S; N S SK
    Emergent Mater; 2021; 4(1):119-130. PubMed ID: 33615141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection.
    Xue Y; Liu C; Andrews G; Wang J; Ge Y
    Nano Converg; 2022 Apr; 9(1):15. PubMed ID: 35366117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
    Gurunathan S; Qasim M; Choi Y; Do JT; Park C; Hong K; Kim JH; Song H
    Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32825737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era.
    Serrano-Aroca Á; Takayama K; Tuñón-Molina A; Seyran M; Hassan SS; Pal Choudhury P; Uversky VN; Lundstrom K; Adadi P; Palù G; Aljabali AAA; Chauhan G; Kandimalla R; Tambuwala MM; Lal A; Abd El-Aziz TM; Sherchan S; Barh D; Redwan EM; Bazan NG; Mishra YK; Uhal BD; Brufsky A
    ACS Nano; 2021 May; 15(5):8069-8086. PubMed ID: 33826850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19.
    England C; TrejoMartinez J; PerezSanchez P; Karki U; Xu J
    Life (Basel); 2023 Feb; 13(3):. PubMed ID: 36983772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy?
    Camlik G; Akkol EK; Degim Z; Degim IT
    Iran J Pharm Res; 2021; 20(4):9-20. PubMed ID: 35194423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection.
    Maiti BK
    ACS Pharmacol Transl Sci; 2020 Aug; 3(4):783-785. PubMed ID: 32821885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases.
    Walker AP; Fan H; Keown JR; Margitich V; Grimes JM; Fodor E; Te Velthuis AJW
    bioRxiv; 2020 Jan; ():. PubMed ID: 32511388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Activity of Nanomaterials against Coronaviruses.
    Muhammad W; Zhai Z; Gao C
    Macromol Biosci; 2020 Oct; 20(10):e2000196. PubMed ID: 32783352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances of nanomaterials-based strategies for fighting against COVID-19.
    Zeng C; Hou X; Bohmer M; Dong Y
    View (Beijing); 2021 Aug; 2(4):20200180. PubMed ID: 34766161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19.
    Raihan T; Rabbee MF; Roy P; Choudhury S; Baek KH; Azad AK
    Front Mol Biosci; 2021; 8():732256. PubMed ID: 34557521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nanotechnology in facing SARS-CoV-2 pandemic: Solving crux of the matter with a hopeful arrow in the quiver.
    Sivasankarapillai VS; Madaswamy SL; Dhanusuraman R
    Sens Int; 2021; 2():100096. PubMed ID: 34766054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
    Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
    Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Drug Strategies to Target Coronaviruses.
    Sarkar K; Sil PC
    Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention.
    Rhazouani A; Aziz K; Gamrani H; Gebrati L; Uddin MS; Faissal A
    Curr Res Pharmacol Drug Discov; 2021; 2():100062. PubMed ID: 34870157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.